Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners, by more than ...

Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced they will reduce the price of the world''s first malaria vaccine ''RTS,S'' for children developed by ...

HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world’s first malaria vaccine, RTS.S. The vac ...

Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world’s first ...

Announcing the funds at Gavi’s global summit in Brussels, Foreign Secretary David Lammy said: “Gavi’s global impact is ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

Hemophilia A, a lifelong bleeding disorder, often causes spontaneous or injury-related bleeding, most commonly in large ...

Manufacturers of the RTS,S shot will begin an immediate phased reduction in cost, with an ultimate aim to reduce the price to ...